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Abstract Casein kinase IK (CKIK) belongs to a family of
serine/threonine protein kinases involved in membrane traffick-
ing, RNA processing, mitotic spindle formation and cell cycle
progression. In this report, we identified several CKIK interact-
ing proteins including RCC1, high mobility group proteins 1 and
2 (HMG1, HMG2), Erf, centaurin-K1, synaptotagmin IX and
CPI-17 that were isolated from brain as CKIK co-purifying
proteins. Actin, importin-K1, importin-L, PP2Ac, centaurin-K1,
and HMG1 were identified by affinity chromatography using a
peptide column comprising residues 214^233 of CKIK. We have
previously shown that centaurin-K1 represents a CKIK partner
both in vitro and in vivo. The nuclear protein regulator of
chromosome condensation 1 (RCC1) is a guanosine nucleotide
exchange factor for Ran which is involved in nuclear transport
and mitotic spindle formation. Here we show that CKIK and
RCC1 interact in brain and in cultured cells. However, the
interaction does not involve residues 217^233 of CKIK which are
proposed from X-ray structures to represent an anchoring site for
CKI partners. Formation of the RCC1/CKIK complex is
consistent with the association of the kinase with mitotic
spindles. In conclusion, we have identified a number of novel
CKIK protein partners and their relations to CKI are
discussed. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Members of the casein kinase I (CKI) family are serine/
threonine protein kinases which are widely expressed in a
number of species ranging from plants to mammals (reviewed
in [1]). Seven isoforms from distinct genes are expressed in
mammals (CKIK, L, N, O, Q1, Q2, Q3). However, many more
CKI forms are generated as a result of alternative splicing.
CKI isoforms contain a highly conserved kinase domain and
variable amino- and carboxy-terminal tails. CKIs appear to be
constitutively active and are not regulated by second messen-
gers. However, CKIN/O activities are modulated by autophos-
phorylation [2^5]. CKI isoforms preferentially phosphorylate
proteins on residues that occur two to three residues down-
stream of an acidic or a phosphorylated residue.
Mammalian CKI isoforms are involved in various biologi-
cal functions. For instance, CKIO and CKIN play a role in the
regulation of p53 [6,7]. CKIO has also been implicated in
circadian rhythms [8] and in the Wnt signalling pathway
[9,10]. CKIN/O are also implicated in membrane tra⁄cking,
in the regulation of centrosome and in spindle formation
[11^13]. CKIQ2 appears to play a role in actin cytoskeleton
organisation [14,15]. CKIK has been shown to play a role in
cell cycle progression [16], in membrane tra⁄cking [17^19]
and in RNA processing [20]. CKIs have also been shown to
regulate the nucleo-cytoplasmic localisation of some of their
substrates [21,22].
CKI isoforms contain a putative nuclear localisation signal
(NLS), a kinesin homology domain and exhibit a high degree
of variation in their subcellular localisations [1]. CKIK has
been shown to localise to synaptic vesicles, to the centro-
somes, with spindle microtubules at mitosis and also to nu-
clear structures such as speckles [17,20,23]. CKIQ2 is present at
the plasma membrane where it associates with membrane re-
ceptors, Pak1 and Nck [14,15,24]. CKIN is associated with
post-Golgi structures, microtubules and the spindle apparatus
[11^13].
Although the yeast CKI isoforms have been well character-
ised, the functions of the mammalian CKI isoforms are much
less known. Therefore, the identi¢cation of mammalian CKI
substrates and binding proteins should help us to clarify their
cellular function(s). CKIK has been shown to interact with the
transcription factor NF-AT4 [21], G protein-coupled recep-
tors [25], the AP3 complex [18], DARPP32 [26] and centaur-
in-K1 [19]. In this report, we have identi¢ed numerous novel
CKIK protein partners. One of these CKIK interacting pro-
teins is the regulator of chromosome condensation 1 (RCC1).
RCC1 is a guanosine exchange factor for the small G protein
Ran which plays a role in nuclear transport and in mitotic
spindle formation (reviewed in [27^29]). We show that RCC1
co-puri¢es with CKIK in brain. RCC1 associates with a CKI
activity in brain and in cultured cells. Moreover, RCC1 inter-
acts with ectopically expressed CKIK in COS-7 cells. Our data
suggest a role for CKIK in mitotic spindle formation which is
in agreement with its association with mitotic spindles [23].
2. Materials and methods
2.1. Identi¢cation of the CKIK co-purifying proteins from brain lysate
by mass spectrometry
We have previously identi¢ed from brain CKIK as a kinase which
phosphorylates 14-3-3 d and j [30] and we found that several proteins
co-puri¢ed with CKIK [19,30]. The identi¢cation of these CKIK co-
purifying proteins was performed by electrospray mass spectrometry
after trypsin digestion as described previously [19].
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2.2. Cell culture
COS-7 cells were obtained from the European Collection of Cell
Cultures. They were maintained in Dulbecco’s modi¢ed Eagle’s me-
dium (Sigma) supplemented with 10% foetal calf serum (Life Tech-
nologies, Inc.) and 1% penicillin/streptomycin (Life Technologies,
Inc.) at 37‡C in a humidi¢ed chamber with 5% CO2.
2.3. Kinase assays on the immunoprecipitates
Brain tissue and cells were lysed as described [19]. Lysates were pre-
cleared with Pansorbin cells (Roche Molecular Biochemicals) and in-
cubated with an a⁄nity-puri¢ed goat polyclonal RCC1 antibody
(Santa Cruz Biotechnology, Inc.). A mixture of protein A and G
(Pharmacia) was then added to precipitate the antibody. A kinase
assay was performed on the bead precipitates as described [19] using
14-3-3 j wild-type or T232A (puri¢ed as in [30]) or the phosphopep-
tide KRRRALSPVASLPGL (where SP is a phosphoserine; New Eng-
land Biolabs) as CKI speci¢c substrates. 14-3-3 j T232A was used as a
control. Kinase assays using 14-3-3 proteins were analysed by SDS^
PAGE followed by autoradiography. In contrast, the phosphopeptide
substrate was spotted on P81 paper squares (Whatman) and washed
four times with 1% phosphoric acid. Radioactivity retained on the
papers was quanti¢ed by liquid scintillation counting [19].
2.4. Transfection and co-immunoprecipitation
COS-7 cells were transfected using Fugene (Roche Molecular Bio-
chemicals) for 24^36 h in 60-mm diameter petri dishes with 4 Wg of
DNA (HA-tagged CKIK wild-type or with the empty vector,
pCDNA3.1). Cells were serum-starved for 16 h and were either stimu-
lated for 10 min with 100 nM insulin (Sigma) or left untreated. The
cells were lysed and RCC1 was immunoprecipitated as described
above. Proteins were transferred onto nitrocellulose (Bio-Rad) and
the presence of HA-CKI was detected by Western blotting with a
rat anti-HA (Roche Molecular Biochemicals) antibody and ECL de-
tection (Amersham Pharmacia Biotech).
2.5. Identi¢cation of proteins which interact with residues 214^233 of
CKIK by a⁄nity chromatography
This experiment was performed as described [19]. Brie£y, rat brain
lysate was loaded onto a 1 ml Sulfo-Link (Pierce) column to which
1 mg of a peptide corresponding to residues 214^233 (C-214FNRTSL-
PWQGLKAATKKQKY233) of CKI was coupled. Brain extract was
also loaded onto a control column. Both columns were washed
extensively and bound proteins were eluted with 1 M NaCl. Eluted
proteins were revealed by mass spectrometry after in-gel trypsin di-
gestion [19] or by Western blotting using high mobility group protein
1 (HMG1; Pharmingen), RCC1 (Santa Cruz Biotechnology, Inc.),
centaurin-K1 [19] and pan 14-3-3 [19] antibodies.
3. Results and discussion
3.1. Identi¢cation of CKIK co-purifying proteins in brain
During the puri¢cation of CKIK from brain as a protein
kinase which phosphorylates 14-3-3 proteins [30], several pro-
teins co-puri¢ed with the kinase after four conventional chro-
matography steps (SP-Sepharose, Blue A⁄-gel Blue, Mono S
and gel ¢ltration) [19]. These co-purifying proteins may rep-
resent novel CKI-partners and we therefore attempted to
identify them by mass spectrometry. These proteins were iden-
ti¢ed as Erf, RCC1, synaptotagmin IX, HMG1/2, centaurin-
K1 and CPI-17 (Table 1). It should be noted that the in vitro
and in vivo association of CKIK with centaurin-K1 has been
shown by our laboratory previously [19].
Some of the proteins that we have identi¢ed here have
previously been implicated in CKI functions. For instance,
HMG1, an architectural DNA binding protein [31,32], has
recently been shown to be phosphorylated by CKI [33]. Erf
is a transcription factor of the Ets family [34] and Ets1 has
been used as an in vitro CKI substrate [3]. Moreover, we have
found that Erf is also phosphorylated in vitro by CKIK and
preliminary data indicate that it occurs within the serine/
threonine-rich domain of Erf (T. Dubois, G. Mavrothalassitis,
and A. Aitken, unpublished data). CPI-17, a protein phospha-
Fig. 1. RCC1 associates in vivo with CKI. A: Brain lysate was incubated with (RCC1 IP) or without (control) RCC1 antibodies and a mixture
of protein A and G was then added. A kinase assay was performed on the precipitates without (open bars) or with a CKI speci¢c phosphopep-
tide as the substrate (closed bars). The presence of radioactivity (32P) incorporated into the peptide was quanti¢ed by liquid scintillation count-
ing and represents CKI activity associated with the beads. B: COS-7 cells lysate from insulin-stimulated cells or unstimulated cells was immu-
noprecipitated with RCC1 antibodies. A kinase assay was performed using no CKI substrate (3), 14-3-3 j wild-type (14-3-3 j WT) or a
mutant of 14-3-3 j whereby the CKI phosphorylation residue was mutated to alanine (14-3-3 j T232A). The kinase assay was analysed on
SDS^PAGE and the gel was autoradiographed. The position of 14-3-3 is indicated as well as the molecular weight markers (kDa). C: COS-7
cells were transfected with a plasmid expressing HA-tagged CKIK (+, top of the ¢gure) or with the empty vector (3, top of the ¢gure). Cells
were lysed and incubated with (+) or without (3) RCC1 antibodies followed by the addition of a mixture of protein A and G. The presence
of CKIK in the immunoprecipitates was detected by Western blotting using a rat anti-HA monoclonal antibody. The position of HA-CKIK is
indicated.
FEBS 26004 12-4-02
T. Dubois et al./FEBS Letters 517 (2002) 167^171168
tase 1 inhibitor [35], associates with and regulates the activity
of members of the CKI family (E. Zemlickova, F.J. Johannes,
A. Aitken, and T. Dubois, manuscript in preparation). Syn-
aptotagmin IX has been shown to associate with a mRNA
binding protein [36]. The association of synaptotagmin IX
with CKIK is interesting in light of evidence which suggests
that CKIK may regulate certain steps of mRNA metabolism
[20].
Therefore, it appears that all the co-purifying proteins we
have identi¢ed are related in some way to the function(s) of
CKI. It also means that the a⁄nity of these proteins is strong
enough to withstand four di¡erent chromatography steps. It is
noteworthy that the interactions between CKI and the co-
purifying proteins may represent in vivo complex(es) as they
were identi¢ed from brain. Whether these proteins interact
simultaneously or in a mutually exclusive manner with CKI
is not known. It is interesting to note that some of the pro-
teins are mainly localised in the nucleus (RCC1, HMG1/2,
centaurin-K1 and Erf). This may explain the observed associ-
ation of CKIK with mitotic spindles and speckles within the
nucleus [1].
3.2. CKIK and RCC1 co-purify in brain
We also identi¢ed RCC1 as a protein which co-puri¢ed
with CKIK (Table 1). RCC1 is a guanosine exchange factor
for Ran, a small G protein of the Ras superfamily. RCC1 has
been involved in nuclear transport and mitotic spindle forma-
tion (reviewed in [27^29]). Importantly, CKIK has been found
to be associated with mitotic spindles [23]. Other members of
the CKI family (CKIN and CKIO) have been proposed to play
a role in the regulation of centrosome or spindle function
during cell division. Both have been found to be recruited
to the centrosomes and to the spindle apparatus [11^13]. In
addition, yeast CKIs have been linked to chromosome segre-
gation and cytokinesis [1]. Moreover, members of the CKI
family contain a kinesin homology domain [37]. Kinesin,
which possesses this domain that has been proposed to be
involved in microtubule interactions, plays a role in the as-
sembly of mitotic spindle and the segregation of chromo-
somes. Therefore, experiments were carried out to characterise
the interaction of RCC1 with CKIK.
3.3. RCC1 associates with a CKI activity in brain
We tested whether RCC1 associates with CKI in brain. For
that purpose, endogenous RCC1 was immunoprecipitated
from brain lysate using RCC1 antibodies. A kinase assay us-
ing a speci¢c CKI phosphopeptide substrate was performed
on the RCC1 immunoprecipitates. Results showed that RCC1
associates with a kinase which is capable of phosphorylating
the speci¢c CKI phosphopeptide substrate (Fig. 1A, ‘RCC1
IP’). The CKI activity is detected only in the RCC1 immuno-
precipitate and not in the control, thus validating the experi-
ment (Fig. 1A, ‘control’). Therefore, results from Fig. 1A
indicate that a CKI activity speci¢cally associates with
RCC1 in brain.
3.4. RCC1 associates with a CKI activity in cultured cells
In order to further con¢rm the endogenous association be-
tween CKI and RCC1, we immunoprecipitated RCC1 from
COS-7 cells and performed a kinase assay using another CKI
substrate. We have previously shown that CKI phosphory-
lates 14-3-3 j on Thr-232 [30]. We have used 14-3-3 j as a
substrate because the CKI phosphopeptide substrate may be
more prone to non-speci¢c phosphorylation. Endogenous
RCC1 associates with a kinase which is able to phosphorylate
14-3-3 j WT but not 14-3-3 j in which the CKI phosphory-
Table 1




HMG1/HMG2 DNA binding proteins
RCC1 mitotic spindle formation, nucleo-cytoplasmic
shuttle
Synaptotagmin IX associates with a mRNA binding protein
Erf transcription factor of the Ets family
(repressor)
CPI-17 protein phosphatase 1 inhibitor
Centaurin-K1 membrane tra⁄cking
We have identi¢ed six proteins by mass spectrometry that we found
to co-purify with CKIK in brain. These proteins are listed in the ta-
ble and their functions are indicated.
Fig. 2. RCC1 does not associate with residues 217^233 of CKIK.
Brain extracts were loaded onto a 1 ml peptide a⁄nity column to
which a peptide corresponding to residues 214^233 (C-
214FNRTSLPWQGLKAATKKQKY233) of CKIK was coupled (CKI
peptide) or onto a control column (control). The columns were
washed, and bound proteins were eluted with 1 M NaCl. Eluted
fractions (elut) and the last washes (wash) were subjected to SDS^
PAGE and analysed by immunoblotting using RCC1 or HMG1
antibodies. Antibodies against centaurin-K1 or 14-3-3 were used as
positive and negative controls, respectively [19]. A brain extract was
also analysed as a positive control for the antibodies (brain lysate).
Fig. 3. A number of brain proteins associate speci¢cally with resi-
dues 217^233 of CKIK. Brain extracts were loaded onto a peptide
column comprising residues 214^233 of CKIK as described in Fig.
2. Eluted proteins were analysed by SDS^PAGE and were visualised
by Coomassie blue staining. The bands were excised and subjected
to trypsin digestion and electrospray mass spectrometry. The peptide
map analysis identi¢ed some of the proteins as importin-K1, impor-
tin-L, actin, tubulin and PP2Ac. The positions of these proteins are
indicated as well as the molecular weight markers (kDa).
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lation site has been mutated to an alanine (14-3-3 j T232A)
(Fig. 1B). In addition, the kinase activity associated with
RCC1 was not sensitive to insulin stimulation. This is consis-
tent with CKI activity which is proposed to be second mes-
senger-independent. In conclusion, Fig. 1B indicates that en-
dogenous RCC1 associates with an endogenous CKI activity
in COS-7 cells.
3.5. RCC1 associates with ectopically expressed CKIK in
cultured cells
To further demonstrate the association between RCC1 and
CKIK, we have transfected COS-7 cells with HA-CKIK. We
have used COS-7 cells as CKIK was found to be expressed
poorly or not at all (not detectable) in other cell lines tested
(discussed in [19]). Endogenous RCC1 was immunoprecipi-
tated and the presence of CKIK in the immunoprecipitate
was detected by Western blot analysis using an anti-HA anti-
body. The results showed that endogenous RCC1 forms a
protein complex with ectopically expressed CKIK in COS-7
cells (Fig. 1C).
3.6. RCC1 does not associate with residues 217^233 from
CKIK
We have previously mapped the centaurin-K1 binding site
within residues 217^233 of CKIK using several approaches
[19]. These residues belong to a loop between helices E and
F of CKIK that have been proposed to be the target region
for protein^protein interactions [38]. A brain extract was
passed through a column to which a peptide comprising res-
idues 217^233 from CKIK was coupled [19]. We tested
whether RCC1 eluted from the peptide column by Western
blotting using RCC1 antibodies. However, we were unable to
identify RCC1 in any of the fractions eluted from the CKI
peptide column (Fig. 2), thus indicating that residues 217^233
of CKIK do not represent the RCC1 binding site. Centaurin-
K1 and 14-3-3 antibodies were used as positive and negative
controls, respectively [19].
3.7. Identi¢cation of HMG1, importin-K1/L, catalytic subunit
of protein phosphatase 2A (PP2Ac), tubulin and actin as
putative CKI partners interacting with residues 217^233 of
the kinase
Several proteins from brain speci¢cally eluted from the CKI
peptide column as judged by Coomassie blue staining (Fig. 3).
We attempted to identify these putative CKI protein partners
by mass spectrometry. Proteins were digested with trypsin and
peptide mass map analysis identi¢ed them as HMG1, impor-
tin-K1, importin-L, PP2Ac and actin (Fig. 3). Therefore, these
proteins represent novel putative CKI partners interacting
with residues 217^233 of CKIK.
Intriguingly, the roles of importins are closely related to
those of RCC1. Indeed, RCC1 activates Ran which uses im-
portin-K/L as e¡ectors in both nuclear transport and spindle
assembly (reviewed in [28]). The ¢nding that importins bound
to the CKI peptide column emphasised a function for CKI in
these biological events and further supports our present re-
sults regarding the CKI/RCC1 association. In addition, im-
portin-K recognises NLS-bearing proteins, and importin-L as-
sociates with the importin-K^NLS complex to facilitate the
transport to the nucleus through the nuclear pore. Interest-
ingly, residues 217^233 of CKIK contain a putative NLS (ami-
no acids KKQK) [1] and we show that these residues repre-
sent the CKI importin binding site. As CKIK is also expressed
in the nucleus, our results suggest that the transportation of
CKI to the nucleus is via its interaction with importin-K1/L.
We also identi¢ed PP2Ac as a protein which speci¢cally
associates with residues 217^233 of CKIK (Fig. 3). In yeast,
a genetic link has been found between CKI and PP2A [39]. In
addition, phosphorylation/dephosphorylation events by the
CKI/PP2A complex are important in endocytosis and actin
cytoskeleton organisation in yeast [40]. PP2Ac and CKI
may form a complex in which the two activities may regulate
each other [40]. Supporting the existence of such a complex,
PP2A has been shown to associate with several protein ki-
nases including casein kinase II [41], calcium-calmodulin-de-
pendent kinase IV [42], p21-activated kinase [43], p70 S6 ki-
nase [43], Raf-1 [44] and cyclic adenosine monophosphate-
dependent protein kinase [45]. Our data suggest that PP2A
also associates with CKI within residues 217^233 but further
experiments are required to characterise the interaction.
Actin was also found to interact with residues 217^233 of
CKIK (Fig. 3). This result is consistent with a report showing
that a protein having CKI activity and a molecular weight of
37 kDa associates with and phosphorylates actin [46]. The Mr
of the kinase suggested that it could be CKIK and we have
found that CKIK phosphorylates actin in vitro (T. Dubois,
S.K. Maciver, and A. Aitken, unpublished data). Taken to-
gether, this suggests that CKIK associates with and phosphor-
ylates actin, and we have mapped the site of interaction to
residues 217^233. Tubulin associates also speci¢cally to the
peptide column (Fig. 3) and it is interesting to ¢nd this protein
in the context of the association of CKI with mitotic spindles.
Finally, we have identi¢ed HMG1 as a protein which asso-
ciates speci¢cally with residues 217^233 of CKIK by Western
blot analysis (Fig. 2). This result strongly supports the idea
that they form a protein complex after our ¢nding that they
co-puri¢ed from brain (Table 1). In support of this ¢nding,
HMG1 has recently been shown to be phosphorylated by CKI
[33].
4. Conclusions
We have identi¢ed numerous potential CKI protein binding
partners including RCC1. Our ¢ndings are consistent with a
role of RCC1 in mitotic spindle formation and the association
of several CKI mammalian isoforms with the mitotic spindle.
However, we do not know whether the association is direct or
via another molecule, and the possibility for RCC1 to be a
substrate for CKI has not been tested yet. In conclusion, the
association of CKI with RCC1 supports a role for this kinase
in mitotic spindle formation. The identi¢cation of RCC1,
HMG1, importin-K1/L, PP2Ac, tubulin, actin, Erf, synapto-
tagmin IX, centaurin-K1 and CPI-17 as CKI protein partners
gives a further insight into the biological roles of CKI. Indeed,
these interactions need to be fully characterised in order to
better understand the role of CKI in mammalian cells.
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